Avisa Diagnostics Inc.
FOGCF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | 06/30/2020 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 735.00K | 270.10K | 332.70K | ||
| Depreciation & Amortization | 6.40K | 3.30K | 2.80K | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 794.40K | 284.60K | 347.30K | ||
| Operating Income | -794.40K | -284.60K | -347.30K | ||
| Income Before Tax | -4.53M | 1.19M | -469.80K | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -4.53M | 1.19M | -469.80K | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -4.53M | 1.19M | -469.80K | ||
| EBIT | -794.40K | -284.60K | -347.30K | ||
| EBITDA | -793.00K | -281.30K | -344.50K | ||
| EPS Basic | -0.14 | 0.52 | -0.21 | ||
| Normalized Basic EPS | -0.09 | 0.34 | -0.13 | ||
| EPS Diluted | -0.14 | 0.52 | -0.21 | ||
| Normalized Diluted EPS | -0.09 | 0.34 | -0.13 | ||
| Average Basic Shares Outstanding | 32.73M | 2.29M | 2.29M | ||
| Average Diluted Shares Outstanding | 32.73M | 2.29M | 2.29M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||